Showing 34,667 results

Filters
Side effects

Peripheral neuropathy and HIV

About HIV
March 2022
Activism & civil society

Quick thinking and planning instrumental for HIV network in Ukraine

Editor's pick
UNAIDS
9 March 2022
Access to healthcare

We cannot let war in Ukraine derail HIV, TB and Covid-19 treatment in eastern Europe

Editor's pick
The Telegraph
9 March 2022
Bone & joint problems

Better adherence to PrEP is associated with more bone loss

News
9 March 2022
Health problems & ageing

Pain and HIV

About HIV
March 2022
Health problems & ageing

French study finds testosterone deficiency more common in men with HIV than in HIV-negative men

Editor's pick
CATIE
8 March 2022
Injectable & long-acting HIV treatment

Injectable cabotegravir plus rilpivirine every two months maintains viral suppression for three years, but carries higher risk of treatment failure

News
8 March 2022
Health services & systems

How to Induce Rage in a Doctor

Editor's pick
HIV and ID Observations
8 March 2022
Women

UNAIDS Executive Director's message on International Women’s Day 2022

Editor's pick
UNAIDS
8 March 2022
Behaviour change interventions

View Over 8,000 AIDS Education Posters!

Editor's pick
POZ
8 March 2022
Ethnic & cultural minorities

Higher risks of cancer for Black men with HIV suggest racial inequities in US health care

News
8 March 2022

aidsmap news: Long COVID more common in people with HIV, Monday 7 March 2022

March 2022
TB treatment

CDC recommends 4-month regimen for drug-susceptible TB

Editor's pick
Healio
7 March 2022
Harm reduction

Study Projects HIV Surge After Scott County Syringe Program Closure

Editor's pick
Filter
7 March 2022
Government, leadership & policy

President Biden’s 2022 State of the Union Address

Editor's pick
HIV.gov
7 March 2022
Chemsex & recreational drug use

Obituary: David Stuart

Editor's pick
The Lancet
7 March 2022
Coronavirus

Long COVID more common in people with HIV

News
7 March 2022
Injectable & long-acting PrEP

MSF response: ViiV will not license new game-changing long-acting HIV prevention drug to generic manufacturers

Editor's pick
Médecins Sans Frontières
4 March 2022
Injectable & long-acting PrEP

ViiV Healthcare statement on voluntary license in enabling access to cabotegravir LA for PrEP in low- and middle-income countries

Editor's pick
ViiV Healthcare
4 March 2022
Undetectable viral load & treatment as prevention

Knowledge of U=U alone is unlikely to eradicate HIV stigma among gay and bisexual men in India, anthropologist argues

News
4 March 2022
HIV in the arts & media

Kia LaBeija's Portraits of Love and Loss From an H.I.V. Childhood

Editor's pick
The New York Times
3 March 2022
HIV in the arts & media

Why Philadelphia remains a flawed but vital portrayal of the AIDS crisis

Editor's pick
Little White Lies
2 March 2022
New & experimental HIV treatments

Top 5 HIV treatment stories from CROI 2022

News
2 March 2022
The search for a cure

Top 5 HIV cure and vaccine stories from CROI 2022

News
2 March 2022